Cited by 52Skin Protection and AgingAcne and Rosacea Treatments and EffectsDermatologic Treatments and Research

Low-dose oral isotretinoin versus topical retinoic acid for photoaging: A randomized, comparative study

Open access
Bagatin, Edileia, Guadanhim, Lilia R. S., Enokihara, Milvia M. S. S., Sanudo, Adriana, Talarico, Sérgio, Miot, Helio A., Gibson, Lawrence·2014·International Journal of Dermatology

Abstract

BACKGROUND: Oral isotretinoin (ISO) is the only drug which promotes prolonged remission or cure of severe acne. It also has other properties, supporting its use for non-acne indications. Retinoic acid (RA) is gold standard treatment for photoaging. ISO for photoaging treatment was reported in non-controlled trials as alternative to RA, which causes skin irritation. OBJECTIVE: To compare clinical, histological, and immunohistochemical effects of low-dose ISO and 0.05% topical RA to treat photoaging. METHODS: Randomized, comparative, evaluator-blinded, single-center study. Twenty-four healthy, Caucasian, 50 to 75-year-old men and women (menopausal or sterilized) with advanced photoaging were included. Twelve subjects received ISO, 20 mg/day, and 12 subjects were treated with RA cream, for six months; both treatments were administered every other day, and moisturizer and sunscreen were also used. Outcome measures included patient assessments, blinded photographic evaluations, Life Quality Index, histological (HE, Verhoeff) and immunohistochemical (p53, collagen type I) evaluations, adverse events, liver function, lipid profile, and blood count. Statistical analysis with generalized estimating equations and repeated measures ANOVA tests was used. RESULTS: Eleven subjects in each group completed the study. Patient and photographic assessments showed overall improvement in skin appearance. Quality-of-life scores were reduced for all subjects. Histological analysis revealed corneal layer diminution, epidermal thickness increase, and elastosis reduction. Immunohistochemical findings revealed significant epidermal p53 reduction and dermal collagen 1 increase. No differences were found between groups; laboratory tests showed no significant alterations. CONCLUSION: Despite being safe and effective, low-dose ISO was not superior to 0.05% RA for advanced photoaging treatment.

Integrity signals

Registry

Crossref · 10.1111/ijd.12191

Cites

69 of 69 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Clinical studies have shown that oral supplementation with vitamin A and its derivatives can alleviate skin photoaging.

    “Clinical studies have shown that oral supplementation with vitamin A and its derivatives can alleviate skin photoaging.”
  • Histological and immunohistochemical analysis revealed elastosis reduction, epidermal thickness increase, corneal layer diminution, dermal collagen 1 increase, and epidermal p53 reduction in facial and forearm skin of 50- to 75-year-old men and women.

    “Histological and immunohistochemical analysis revealed elastosis reduction, epidermal thickness increase, corneal layer diminution, dermal collagen 1 increase, and epidermal p53 reduction in the facial and forearm skin of 50- to 75-year-old men and women [17].”

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Bagatin, E., Guadanhim, L. R. S., Enokihara, M. M. S. S., Sanudo, A., Talarico, S., Miot, H. A., & Gibson, L.
Affiliations
  • Department of Dermatology; Universidade Federal de São Paulo (UNIFESP); SN Botucatu SP Brazil
  • Universidade Federal de São Paulo (BR)
Venue
International Journal of Dermatology
Publisher
Wiley
Published
2013-10-29
Volume
53
Issue
1
Pages
114-122
ISSN
0011-9059 (ISSN-L)
OpenAlex
W1983342608
Cited by
52
References
69
Citations by year
2026: 1 · 2025: 4 · 2024: 1 · 2023: 8 · 2022: 6 · 2021: 5 · 2020: 5 · 2019: 3 · 2018: 4 · 2017: 7 · 2016: 4 · 2015: 4
FWCI
3.12
Type
journal article
Language
en
Open access
Locations
  • International Journal of Dermatology (publishedVersion)
  • PubMed (publishedVersion)
  • Americanae (AECID Library) (submittedVersion)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
Topics
  • Health Sciences › Medicine › Dermatology › Skin Protection and Aging
  • Health Sciences › Medicine › Dermatology › Acne and Rosacea Treatments and Effects
  • Health Sciences › Medicine › Dermatology › Dermatologic Treatments and Research
Keywords
isotretinoin, topical retinoic acid, photoaging, skin aging, type I collagen, p53, elastosis, epidermal thickness, quality of life, adverse events, liver function
MeSH terms
Administration, Oral, Administration, Topical, Aged, Dermatologic Agents, Facial Dermatoses, Female, Humans, Keratolytic Agents, Male, Middle Aged, Tretinoin, Isotretinoin, Skin Aging, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review